![MEI Pharma Inc](/common/images/company/N_MEIP.png)
MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical deve... MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States. Show more
Company Commences a Cash Preservation Plan Including a Reduction in Force MEI Pharma, Inc. (Nasdaq: MEIP) (the “Company”) today announced that its Board of Directors has determined unanimously to...
-- Ongoing Phase 1 Study Evaluating Voruciclib Plus Venetoclax Demonstrates Anti-leukemic Activity, Including Complete Responses, Anticipated Decreases in Mcl-1 and No Overlapping Toxicity in...
– MEI Pharma Board Unanimously Determines, Based on Clinical Data Results, Not to Proceed with Second Capital Return Under 2023 Anson and Cable Car Cooperation Agreement: Conserving Capital...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.69 | 24.0418118467 | 2.87 | 4.1 | 2.835 | 1072376 | 3.47622436 | CS |
4 | 0.72 | 25.3521126761 | 2.84 | 4.1 | 2.78 | 306910 | 3.45713215 | CS |
12 | 0.43 | 13.7380191693 | 3.13 | 4.1 | 2.7293 | 112019 | 3.39561063 | CS |
26 | -1.04 | -22.6086956522 | 4.6 | 4.97 | 2.7293 | 61800 | 3.50220089 | CS |
52 | -3.76 | -51.3661202186 | 7.32 | 7.8734 | 2.7293 | 53292 | 4.78318266 | CS |
156 | -47.84 | -93.0739299611 | 51.4 | 71 | 2.7293 | 1228895 | 17.85622586 | CS |
260 | -31.04 | -89.710982659 | 34.6 | 91.5 | 2.7293 | 1104395 | 31.48779953 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.